Showcasing Preliminary Results from a Phase I/II, FIH Study of MGC018 in Patients with Advanced Solid Tumours
Time: 11:00 am
day: Track C - Day 2
Details:
- Examine B7H3 as a target for an ADC with a duocarmycin payload
- Presenting a safety overview from Phase 1
- Analyse efficacy from preliminary evidence of a Phase 1